Shares of Alkem Laboratories Ltd. are in focus as promoter Jayanti Sinha is set to offload a 1.42% stake in the pharmaceutical company through a block deal worth ₹825 crore. The transaction is expected to be executed today, with Axis Capital acting as the broker.
🔴 Key Details of the Deal:
- Floor price set at ₹4,850 per share, reflecting a 3% discount to the last traded price.
- Alkem shares closed at ₹4,989, down 2.15% on the BSE.
- Sinha currently holds a 2.46% stake, while the promoter group collectively owns 55.13% of the company.
📢 Market Reaction & Financial Performance:
- Alkem Laboratories reported a 4.26% YoY rise in net profit at ₹306 crore for Q4FY25, missing analyst estimates.
- Revenue grew 7.1% YoY to ₹3,144 crore, slightly below expectations.
- The stock has risen 6.5% since the last block deal in February, but remains down 10% in 2025.
⚠️ Strategic Impact:
This sale follows a previous promoter stake sale in February, where Samprada & Nanhamati Singh Family Trust offloaded 0.54% stake for ₹300.3 crore. Investors are closely watching how the market absorbs this large stake sale.
👉 What do you think of this market move? Let us know in the comments!
🔴 Share this post to keep investors informed! 📊🔥
